FY18
Assets77.62
Net Worth16.79
Total Debt47.63
RevenueAnnualised basis59.41
EBITDAAnnualised basis12.74
PATAnnualised basis3.75
EBITDA Margin (%)21.44
At a glance
Updated 2026-09-06Cian Healthcare is an IPO with an issue size of ₹37.92 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹37.92 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets85.90₹ Cr · +51.2% vs prior year
Net Worth25.35₹ Cr · +134.7% vs prior year
FY17
Assets61.27
Net Worth13.04
Total Debt39.66
RevenueAnnualised basis51.78
EBITDAAnnualised basis9.99
PATAnnualised basis2.33
EBITDA Margin (%)19.29
FY16
Assets56.81
Net Worth10.80
Total Debt31.05
RevenueAnnualised basis46.68
EBITDAAnnualised basis7.88
PATAnnualised basis1.37
EBITDA Margin (%)16.88
31-Dec-18
Assets85.90
Net Worth25.35
Total Debt43.36
RevenueAnnualised basis44.07
EBITDAAnnualised basis12.41
PATAnnualised basis5.25
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Cian Healthcare IPO | — | 21.66 x | — | — |
| Bio Medica IPO | — | 13.45 x | — | — |
| Goldline Pharmaceutical IPO | — | 14.56 x | — | — |
| Speciality Medicines IPO | — | 10.49 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-06.
IPO UPDATE ALERTS
Register for IPO Updates →Track Cian Healthcare without missing an update
Register for subscription, GMP, allotment and listing notifications.